GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » E10

Abattis Bioceuticals (Abattis Bioceuticals) E10 : $-0.03 (As of Sep. 2019)


View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Abattis Bioceuticals's adjusted earnings per share data for the three months ended in Sep. 2019 was $-0.004. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.03 for the trailing ten years ended in Sep. 2019.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-07), Abattis Bioceuticals's current stock price is $0.0001. Abattis Bioceuticals's E10 for the quarter that ended in Sep. 2019 was $-0.03. Abattis Bioceuticals's Shiller PE Ratio of today is .


Abattis Bioceuticals E10 Historical Data

The historical data trend for Abattis Bioceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals E10 Chart

Abattis Bioceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.11 -0.03

Abattis Bioceuticals Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.08 -0.05 -0.05 -0.03

Competitive Comparison of Abattis Bioceuticals's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Abattis Bioceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abattis Bioceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abattis Bioceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Abattis Bioceuticals's Shiller PE Ratio falls into.



Abattis Bioceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abattis Bioceuticals's adjusted earnings per share data for the three months ended in Sep. 2019 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2019 (Change)*Current CPI (Sep. 2019)
=-0.004/107.6113*107.6113
=-0.004

Current CPI (Sep. 2019) = 107.6113.

Abattis Bioceuticals Quarterly Data

per share eps CPI Adj_EPS
200912 0.000 90.703 0.000
201003 -0.049 91.335 -0.058
201006 -0.048 91.809 -0.056
201009 -0.097 92.362 -0.113
201012 0.000 92.836 0.000
201103 0.000 94.338 0.000
201106 -0.051 94.654 -0.058
201109 -0.040 95.286 -0.045
201112 -0.010 94.970 -0.011
201203 -0.020 96.155 -0.022
201206 -0.019 96.076 -0.021
201209 -0.041 96.392 -0.046
201212 -0.020 95.760 -0.022
201303 -0.010 97.103 -0.011
201306 -0.010 97.182 -0.011
201309 0.000 97.419 0.000
201312 -0.009 96.945 -0.010
201403 -0.117 98.604 -0.128
201406 -0.009 99.473 -0.010
201409 -0.014 99.394 -0.015
201412 -0.010 98.367 -0.011
201503 -0.008 99.789 -0.009
201506 -0.008 100.500 -0.009
201509 -0.023 100.421 -0.025
201512 -0.007 99.947 -0.008
201603 -0.008 101.054 -0.009
201606 -0.003 102.002 -0.003
201609 -0.015 101.765 -0.016
201612 -0.007 101.449 -0.007
201703 -0.015 102.634 -0.016
201706 -0.015 103.029 -0.016
201709 -0.016 103.345 -0.017
201712 -0.023 103.345 -0.024
201803 -0.031 105.004 -0.032
201806 -0.015 105.557 -0.015
201809 -0.123 105.636 -0.125
201812 -0.002 105.399 -0.002
201903 0.000 106.979 0.000
201906 -0.001 107.690 -0.001
201909 -0.004 107.611 -0.004

Add all the adjusted EPS together and divide 10 will get our e10.


Abattis Bioceuticals  (OTCPK:ATTBF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Abattis Bioceuticals E10 Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Traded in Other Exchanges
N/A
Address
1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.

Abattis Bioceuticals (Abattis Bioceuticals) Headlines